Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden
Open Access
- 1 August 2012
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 130 (2), 285-292
- https://doi.org/10.1542/peds.2012-0139
Abstract
BACKGROUND AND OBJECTIVE: Optimal treatment decisions in children require sufficient evidence on the safety and efficacy of pharmaceuticals in pediatric patients. However, there is concern that not enough trials are conducted in children and that pediatric trials differ from those performed in adults. Our objective was to measure the prevalence of pediatric studies among clinical drug trials and compare trial characteristics and quality indicators between pediatric and adult drug trials. METHODS: For conditions representing a high burden of pediatric disease, we identified all drug trials registered in ClinicalTrials.gov with start dates between 2006 and 2011 and tracked the resulting publications. We measured the proportion of pediatric trials and subjects for each condition and compared pediatric and adult trial characteristics and quality indicators. RESULTS: For the conditions selected, 59.9% of the disease burden was attributable to children, but only 12.0% (292/2440) of trials were pediatric (P < .001). Among pediatric trials, 58.6% were conducted without industry funding compared with 35.0% of adult trials (P < .001). Fewer pediatric compared with adult randomized trials examined safety outcomes (10.1% vs 16.9%, P = .008). Pediatric randomized trials were slightly more likely to be appropriately registered before study start (46.9% vs 39.3%, P = .04) and had a modestly higher probability of publication in the examined time frame (32.8% vs 23.2%, P = .04). CONCLUSIONS: There is substantial discrepancy between pediatric burden of disease and the amount of clinical trial research devoted to pediatric populations. This may be related in part to trial funding, with pediatric trials relying primarily on government and nonprofit organizations.Keywords
This publication has 39 references indexed in Scilit:
- The ClinicalTrials.gov Results Database — Update and Key IssuesNew England Journal of Medicine, 2011
- The Quality of Registration of Clinical TrialsPLOS ONE, 2011
- A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007BMC Pediatrics, 2010
- Evolution of paediatric off‐label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994–2007British Journal of Clinical Pharmacology, 2010
- Controlled Trials in Children: Quantity, Methodological Quality and Descriptive Characteristics of Pediatric Controlled Trials Published 1948-2006PLOS ONE, 2010
- Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and ResultsPLoS Medicine, 2008
- Publication of Clinical Trials Supporting Successful New Drug Applications: A Literature AnalysisPLoS Medicine, 2008
- WHO launches campaign to make drugs safer for childrenBMJ, 2007
- Regulation of drugs for children in EuropeBMJ, 2007
- Off‐label and unlicensed prescribing for children: have we made any progress?British Journal of Clinical Pharmacology, 2007